Stock screener

MLTX

Conviction 17HealthcareScan · Thu, Sep 24, 2026

MoonLake Immunotherapeutics (MLTX) closed at $12.12 (-6.05%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 6, -80.5% from its 52-week high, +1.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

MLTX$12.12-6.05%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.89M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
MoonLake ImmunotherapeuticsPHARMACEUTICAL PREPARATIONSwww.moonlaketx.com ↗
Price12.12
Change-6.05%
Gap-1.71%
Rel volume1.23×
Avg volume1.6M
Avg $ vol21.34M
SMA 2013.67
SMA 5016.08
SMA 20016.86
Price vs 50-24.60%
Price vs 200-28.11%
MA stackbearish
50/200 crossdeath · 5d
Supertrenddown · 14.34
RSI (14)31
MACD hist0.05
MACD crossbull · 2d
Stoch %K / %D7 / 26
ADX (14)40
+DI / −DI14 / 27
RSI divergence—
MACD divergence—
ATR %6.31%
ADR %5.14%
52w high61.99
52w low6.25
From 52w high-80.45%
Above 52w low+94.08%
New 52w highNo
SqueezeOff
Bollinger width36.32%
%B0.19
Donchian pos6.15%
Donchian high15.78
Donchian low11.88
AVWAP (52w high)12.62
vs AVWAP high-4.00%
AVWAP (52w low)12.53
vs AVWAP low-3.31%
OBV trendDown
Chaikin MF (20)-0.12
Today vs 20d1.23×
Avg vol (14d)1.89M
Avg vol (20d)1.6M
Avg $ vol (20d)21.34M
Market cap1.03B
RS Rating6 / 99
RS 3m (vs SPY)-43.86%
RS 6m (vs SPY)-49.56%
RS line new highNo
Trend template3/8
Technical rank10.4
1 week-1.86%
1 month-22.11%
3 months-39.37%
6 months-32.74%
1 year-76.93%
YTD+1.42%
P/E-4.54
P/B2.41
P/S—
P/FCF-5.26
EPS-3.53
Div yield—
ROE-53.09%
ROA-39.61%
Debt/Eq0.23
Current12.56
EV/EBITDA-2.70
Gross margin—
Net margin—
Rev growth—
EPS growth-91.13%
Price target33.43
Target upside175.83%
Analyst ratingBuy
Institutional90.73%
Ent. value653.1M
Revenue—
Net income-61.8M
Gross profit—
Free cash flow-196.04M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out73.62M
Employees130
ListedWed, Apr 6, 2022
Free float43.93M
Float %61.3%
Short interest7.14M
Days to cover6.7d
Short volume42.0%
Squeeze score62 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.84 vs −$0.90
Last surprise+6.7% beat
Setup gradeD
Conviction17 / 100
Pattern quality—
Tech rank10.4 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance18.18
Support13.26
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MLTX

All disclosures →
No recent disclosed trades by Congress in MLTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MLTX · open-market 5 sells

InsiderSideShares
Santos da Silva Jorge
Chief Executive Officer · Class A ordinary shares, par value $0.0001 per share · 2026-07-10
Sell68.29K
Santos da Silva Jorge
Chief Executive Officer · Class A ordinary shares, par value $0.0001 per share · 2026-07-09
Sell33.94K
BVF PARTNERS L P/IL
Director · Option to Buy · 2026-06-17
Grant22.2K
Bodenstedt Matthias
Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-06-18
Sell2.79K
Phillips Andrew John
Director · Option to Buy · 2026-06-17
Grant22.2K
Moukheibir Catherine
Director · Option to Buy · 2026-06-17
Grant22.2K
Xavier Ramnik
Director · Option to Buy · 2026-06-17
Grant22.2K
Bodenstedt Matthias
Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-06-17
Sell15.08K
Loy Spike
Director · Option to Buy · 2026-06-17
Grant22.2K
Bodenstedt Matthias
Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-05-11
Sell13.65K

SEC filings

EDGAR filings in MLTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.